Feedback / Questions
SRA141 - Sierra Oncology
SRA737 - Sierra Oncology
momelotinib (CYT 387) - Sierra Oncology
https://www.biospace.com/article/releases/sierra-oncology-launches-campaign-exploring-non-dilutive-strategic-options-to-support-development-of-its-ddr-assets/
Jun 27, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next